FDA 483 - Tolmar, Inc. - December 06, 2017

TOLMAR, Inc. in Fort Collins, CO, a drug manufacturer, received a Form 483 with two observations. The inspection revealed deficiencies in computer system controls, specifically regarding unique user accounts and data integrity, as well as inadequate supplier qualification practices for raw materials. These issues indicate potential risks to product quality and data reliability.